Related references
Note: Only part of the references are listed.Angiogenic markers endoglin and vascular endothelial growth factor in gastroenteropancreatic neuroendocrine tumors
Patricia Kuiper et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Sialic acid-binding dwarf elder four-chain lectin displays nucleic acid N-glycosidase activity
Rosario Iglesias et al.
BIOCHIMIE (2010)
Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours
Ester Fonsatti et al.
CARDIOVASCULAR RESEARCH (2010)
An evolved ribosome-inactivating protein targets and kills human melanoma cells in vitro and in vivo
Melissa C. Cheung et al.
MOLECULAR CANCER (2010)
Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease
Tom G. Obrig
TOXINS (2010)
Tumor Angiogenesis: Insights and Innovations
Fernando Nussenbaum et al.
JOURNAL OF ONCOLOGY (2010)
Expression of endoglin (CD105) in cervical cancer
H. J. Zijlmans et al.
BRITISH JOURNAL OF CANCER (2009)
Ricin A Chain Insertion into Endoplasmic Reticulum Membranes Is Triggered by a Temperature Increase to 37 °C
Peter U. Mayerhofer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Targeted therapy of cancer using diphtheria toxin-derived immunotoxins
Sirisha Potala et al.
DRUG DISCOVERY TODAY (2008)
Transient occurrence of an ebulin-related-D-galactose-lectin in shoots of Sambucus ebulus L.
Lucia Citores et al.
PHYTOCHEMISTRY (2008)
Cytosolic chaperones influence the fate of a toxin dislocated from the endoplasmic reticulum
Robert A. Spooner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Targeting a marker of the tumour neovasculature using a novel anti-human CD105-immunotoxin containing the non-toxic type 2 ribosome-inactivating protein nigrin b
Raquel Munoz et al.
CANCER LETTERS (2007)
Immunotoxin treatment of cancer
Ira Pastan et al.
ANNUAL REVIEW OF MEDICINE (2007)
Crystallization and preliminary X-ray diffraction analysis of PD-L1, a highly glycosylated ribosome inactivating protein with DNase activity
Alessia Ruggiero et al.
PROTEIN AND PEPTIDE LETTERS (2007)
CD105-assessed micro-vessel density is associated with malignancy recurrence in laryngeal squamous cell carcinoma
G. Marioni et al.
EJSO (2006)
Immunotoxins in the treatment of hematologic malignancies
Robert J. Kreitman et al.
CURRENT DRUG TARGETS (2006)
Immunotoxins for targeted cancer therapy
Robert J. Kreitman
AAPS JOURNAL (2006)
Specific dose-dependent damage of Lieberkuhn crypts promoted by large doses of type 2 ribosome-inactivating protein nigrin b intravenous injection to mice
MJ Gayoso et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2005)
Enzymatic activity of toxic and non-toxic type 2 ribosome-inactivating proteins
L Barbieri et al.
FEBS LETTERS (2004)
Characterization and cDNA cloning of monomeric lectins that correspond to the B-Chain of a type 2 ribosome-inactivating protein from the bark of Japanese elderberry (Sambucus sieboldiana)
MA Rojo et al.
JOURNAL OF BIOCHEMISTRY (2004)
High interstitial fluid pressure -: An obstacle in cancer therapy
CH Heldin et al.
NATURE REVIEWS CANCER (2004)
Cytotoxic ribosome-inactivating lectins from plants
MR Hartley et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2004)
Interaction of volkensin with HeLa cells:: binding, uptake, intracellular localization, degradation and exocytosis
MG Battelli et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
Immunotoxins and other conjugates: Pre-clinical studies
A Bolognesi et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2004)
Description, distribution, activity and phylogenetic relationship of ribosome-inactivating proteins in plants, fungi and bacteria
T Girbés et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2004)
Immunotoxins and other conjugates: Preparation and general characteristics
G Fracasso et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2004)
Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels
E Fonsatti et al.
ONCOGENE (2003)
Immunotoxin therapy of hematologic malignancies
AE Frankel et al.
SEMINARS IN ONCOLOGY (2003)
cDNA molecular cloning and seasonal acumulation of an ebulin 1-related dimeric lectin of dwarf elder (Sambucus ebulus L.) leaves
MA Rojo et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2003)
Isolation and characterization of a new D-galactose-binding lectin from Sambucus racemosa L.
MA Rojo et al.
PROTEIN AND PEPTIDE LETTERS (2003)
CD105 is important for angiogenesis: evidence and potential applications
SE Duff et al.
FASEB JOURNAL (2003)
Identification of the ricin lipase site and implication in cytotoxicity
J Morlon-Guyot et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Lineage specific treatment of adult patients with acute lymphoblastic leukemia in first remission with anti-B4-blocked ricin or high-dose cytarabine - Cancer and leukemia group B study 9311
TP Szatrowski et al.
CANCER (2003)
Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway
ZM Qian et al.
PHARMACOLOGICAL REVIEWS (2002)
Targeting cancer cells with transferrin conjugates containing the non-toxic type 2 ribosome-inactivating proteins nigrin b or ebulin 1
L Citores et al.
CANCER LETTERS (2002)
Lipolytic activity of ricin from Ricinus sanguineus and Ricinus communis on neutral lipids
S Lombard et al.
BIOCHEMICAL JOURNAL (2001)
Sensitivity of cancer cell lines to the novel non-toxic type 2 ribosome-inactivating protein nigrin b
R Muñoz et al.
CANCER LETTERS (2001)
2.8-Å crystal structure of a nontoxic type-II ribosome-inactivating protein, ebulin 1
JM Pascal et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2001)
The effect of a monoclonal antibody coupled to ricin A chain-derived peptides on endothelial cells in vitro:: Insights into toxin-mediated vascular damage
R Baluna et al.
EXPERIMENTAL CELL RESEARCH (2000)
Imaging of tumour neovasculature by targeting the TGF-β binding receptor endoglin
S Bredow et al.
EUROPEAN JOURNAL OF CANCER (2000)
Targeted toxin therapy for malignant astrocytoma
WA Hall
NEUROSURGERY (2000)
Share Paper
